ChampionX Co. (NASDAQ:CHX - Free Report) - Analysts at Capital One Financial lowered their FY2024 EPS estimates for shares of ChampionX in a report released on Monday, October 21st. Capital One Financial analyst D. Becker now expects that the company will earn $1.67 per share for the year, down from their previous estimate of $1.97. The consensus estimate for ChampionX's current full-year earnings is $1.99 per share. Capital One Financial also issued estimates for ChampionX's Q4 2024 earnings at $0.39 EPS, Q1 2025 earnings at $0.35 EPS, Q2 2025 earnings at $0.41 EPS, Q3 2025 earnings at $0.44 EPS, Q4 2025 earnings at $0.47 EPS and FY2025 earnings at $1.67 EPS.
ChampionX (NASDAQ:CHX - Get Free Report) last released its quarterly earnings data on Wednesday, October 23rd. The company reported $0.44 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.01). ChampionX had a net margin of 8.66% and a return on equity of 19.72%. The firm had revenue of $906.53 million during the quarter, compared to the consensus estimate of $916.50 million. During the same quarter in the previous year, the firm earned $0.41 earnings per share. The business's revenue was down 3.5% compared to the same quarter last year.
Separately, Piper Sandler cut their price objective on shares of ChampionX from $40.00 to $33.00 and set a "neutral" rating for the company in a report on Monday, July 15th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to MarketBeat.com, ChampionX presently has a consensus rating of "Moderate Buy" and an average price target of $39.00.
Get Our Latest Report on ChampionX
CHX stock opened at $29.65 on Thursday. The stock has a market capitalization of $5.65 billion, a PE ratio of 16.11, a price-to-earnings-growth ratio of 1.27 and a beta of 2.37. The company has a quick ratio of 1.25, a current ratio of 1.99 and a debt-to-equity ratio of 0.34. ChampionX has a 52 week low of $25.46 and a 52 week high of $39.95. The firm has a 50 day moving average of $30.63 and a 200 day moving average of $32.43.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Friday, October 4th will be paid a dividend of $0.095 per share. The ex-dividend date of this dividend is Friday, October 4th. This represents a $0.38 dividend on an annualized basis and a dividend yield of 1.28%. ChampionX's payout ratio is currently 20.65%.
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Allspring Global Investments Holdings LLC purchased a new stake in shares of ChampionX during the first quarter worth approximately $27,000. Blue Trust Inc. raised its position in ChampionX by 442.4% during the 3rd quarter. Blue Trust Inc. now owns 1,329 shares of the company's stock worth $44,000 after buying an additional 1,084 shares during the last quarter. DekaBank Deutsche Girozentrale acquired a new stake in shares of ChampionX in the 2nd quarter worth $68,000. UMB Bank n.a. boosted its holdings in shares of ChampionX by 63.7% in the third quarter. UMB Bank n.a. now owns 2,266 shares of the company's stock valued at $68,000 after acquiring an additional 882 shares in the last quarter. Finally, Central Pacific Bank Trust Division acquired a new position in shares of ChampionX during the first quarter worth about $136,000. 98.99% of the stock is currently owned by institutional investors and hedge funds.
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.